Complementary and alternative medicine in Japan

Advances in Experimental Medicine and Biology

Volumn 546, Issue , 2004, Pages 9-25

  Suzuki, Nobutaka ^a   Ohno, Satoshi ^b   Kamei, Tsutomu ^b   Yoshiki, Yumiko ^b   Kikuchi, Yuji ^b   Okubo, Kazuyoshi ^b   Ohta, Tomihisa ^b   Shimizu, Shoji ^b   Koshimura, Saburo ^b   Taru, Atsufumi ^b   Inoue, Masaki ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; EPHEDRA EXTRACT; KAVA; N NITROSO FENFLURAMINE; PYCNOGENOL; REACTIVE SULFUR SPECIES; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; BLOOD RHEOLOGY; CANCER PREVENTION; CANCER THERAPY; CHEMOLUMINESCENCE; CONFERENCE PAPER; CURRICULUM; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG FATALITY; GOVERNMENT; HEALTH CARE SYSTEM; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; JAPAN; LIVER DYSFUNCTION; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICAL SCHOOL; MEDICAL SOCIETY; PRIORITY JOURNAL; UNITED STATES;

EPHEDRA; PIPER METHYSTICUM;

EID: 19944429910     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-4820-8_3     Document Type: Conference Paper

References (30)

1. W. B. Jonas, Researching alternative medicine, Nat. Med. 3, 824-82 (1997).
2. J. Couzin, Beefed-up NIH center probes unconventional therapies, Science. 282, 2175-2176 (1998).
3. JAMA patient page, Alternative medicine, JAMA. 280, 1640 (1998).
4. D. M. Eisenberg, R. C. Kessler, C. Foster, F. E. Norlock, D. R. Calkins, and T. L. Delbanco, Unconventional medicine in the United States. Prevalence, costs, and patterns of use, N. Eng. J. Med. 328, 246-252 (1993).
5. D. M. Eisenberg, R. B. Davis, S. J. Ettner, S. Wilkey, S. Van, M. Rompay, and R. C. Kessler, Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey, JAMA. 280, 1569-1575 (1998).
6. P. Fisher and A. Ward, Complementary medicine in Europe, BMJ. 309, 107-111 (1994).
7. S. J. Fulder and R. E. Munro, Complementary medicine in the United Kingdom: patients, practitioners, and consultations, Lancet. 2, 542-545 (1985).
8. A.H. Maclennan, D. H. Wilson, and A. W. Taylor, Prevalence and costs of alternative medicine in Australia, Lancet. 347, 569-573 (1996).
9. S. Kamohara, in: Alternative Medicine (Tyuou Kouron Shinsha, Tokyo, 2002), pp. 30-35.
10. H. Yamashita, H. Tsukayama, and C. Sugishita, Popularity of complementary and alternative medicine in Japan: a telephone survey, Complement. Ther. Med. 10, 84-93 (2002).
11. M. S. Wetzel, D. M. Eisenberg, and T. J. Kaptchuk, Courses involving complementary and alternative medicine at US medical schools, JAMA. 280, 784-787 (1998).
12. J. Ruedy, D. M. Kaufman, and H. MacLeod, Alternative and complementary medicine in Canadian medical schools, Can. Med. Assoc. J. 160, 816-817 (1999).
13. H. Rampes, F. Sharples, S. Maragh, and P. Fisher, Introducing complementary medicine into the medical curriculum, J. R. Soc. Med. 90, 19-22 (1997).
14. K. Tsuruoka, Y. Tsuruoka, and E. Kajii, Complementary medicine education in Japanese medical schools: a survey, Complement. Ther. Med. 9, 28-33 (2001).
15. S. Hosseini, S. Pishnamazi, S. M. Sadrzadef, F. Farid, R. Farid, and R. R. Watson, Pycnogenol in the management of asthma, J. Med. Food. 4, 201-209 (2001).
16. F. Schonlau and P. Rhodewald, Pycnogenol for diabetic retinopathy. A review, Int. Opthalmol. 24, 161-171 (2001).
17. S. J. Roseff, Improvement in sperm quality and function with French maritime pine tree bark extract, J. reprod. Med. 47, 821-824 (2002).
18. Z. Ni, Y. Mu, and O. Gulati, Treatment of melasma with pycnogenol, Phytother. Res. 16, 567-571 (2002).
19. T. Kohama and N. Suzuki, The treatment of gynaecological disorders with pycnogenol, Eur. Bull. Drug. Res. 7, 30-32 (1999).
20. Y. Yoshiki, K. Okubo, and T. Kanazawa, Effects of cigarette smoking on the photon emission from plasma, ITF. Letters. 1, 65-68 (2000).
21. Y. Yoshiki, T. Iida, K. Okubo, and T. Kanazawa, Chemiluminescence of hemoglobin and identification of related compounds with the hemoglobin Chemiluminescence in plasma, Photochem. Photobiol. 73, 545-550 (2001).
22. Y. Yoshiki, T. Iida, Y. Akiyama, K. Okubo, H. Matsumoto, and M. Sato, Imaging of hydroperoxide and hydrogen peroxide scavenging substances by photon emission, Luminescence. 16, 1-9 (2001).
23. H. Matsumoto, Y. Nakamura, M. Hirayama, Y. Yoshiki, and K. Okubo, Antioxidant activity of black currant anthocyanin aglycons and thieir glycosides measured by chemiluminescnece in neutral pH region and in human plasma, J. Agric. Food Chem. 50, 5034-5037 (2002).
24. Y. Kikuchi, K. Sato, H. Ohki, and T. Kaneko, Optically accessible microchannels formed in a single-crystal silicon substrate for studies of blood rheology, Microvasc. Res. 44, 226-240 (1992).
25. Y. Kikuchi, K. Sato, and Y. Mizuguchi, Modified cell-flow microchannels in a single-crystal silicon substrate and flow behavior of blood cells, Microvasc. Res. 47, 126-139 (1994).
26. Y. Kikuchi and H. E. Kikuchi, Measurement of oxidative stress by leukocytes using microchannel array flow analyzer and effects of food substances, Microcirc. Ann. 15, 153-154 (1999).
27. Y. Kikuchi, Relation between whole blood fluidity through capillaries and hematocrit, Microcirc. Ann. 16, 37-38 (2000).
28. T. Kamei, H. Kumano, K. Iwata, and M. Yasushi, Influences of long-and short-distance driving on alpha waves and natural killer cell activity, Percept. Mot. Skills. 87, 1419-1423 (1998).
29. T. Kamei, Y. Toriumi, S. Nagura, H. Kumano, H. Otani, M. Yasushi, and S. Jimbo, Influence of forehead exposure to red photodiode light on frontal alpha wave amplitude and CD57-CD16+ level, Photomed. Photobiol. 21, 115-121 (1999).
30. T. Kamei, Y. Toriumi, H. Kumano, M. Fukada, and T. Matsumoto, Use of photic feedback as an adjunct tratment in a case of Miller Fisher syndrome, Perceptual. Motor. Skills. 90, 262-264 (2000).